Targeting GHR in multiple types of human cancers has been hypothesized and shown to significantly attenuate tumor resistance to multiple antineoplastic approaches, including radiation therapy, chemotherapy, targeted therapy, and immunotherapy [10]. Here, GHR is linked to neoplasm.